New knowledge of the pathogenesis of vitiligo (ICD-10-CM L80) has given rise to new treatments and new hope for sufferers of this condition, says Pearl E. Grimes, M.D. She is director of the Vitiligo and Pigmentation Institute of Southern California and clinical professor of dermatology at The University of California Los Angeles David Geffen School of Medicine.

Dr. Grimes spoke about vitiligo at MauiDerm 2016.

Read the full article at